Physician profile
John H Kirk
NPI 1922020783
$6,665.71
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $985 · 2020: $3,712 · 2021: $1,780 · 2022: $90.35 · 2023: $54.61 · 2024: $43.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $78.67 · Education: $19.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $78.67 |
| Education | $19.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,272.89 | 2019-2020 | |
| Caldera Medical, INC | $1,094.07 | 2019-2021 | |
| Axonics, INC. | $889.60 | 2021 | |
| Conmed Corporation | $665.55 | 2020-2021 | |
| Abbvie INC. | $143.13 | 2019-2021 | |
| Amag Pharmaceuticals, INC. | $103.08 | 2020 | |
| Therapeuticsmd, INC. | $94.69 | 2019-2021 | |
| Olympus America INC. | $58.11 | 2019-2020 | |
| Pfizer INC. | $55.76 | 2023-2024 | |
| Organon LLC | $47.39 | 2022 | |
| Myovant Sciences INC. | $42.96 | 2022 | |
| Stryker Corporation | $42.13 | 2021 | |
| Merck Sharp & Dohme LLC | $39.45 | 2019-2020 | |
| Mimedx Group, INC. | $24.83 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.33 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $21.25 | 2019 | |
| Aspira Women'S Health INC | $17.59 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.35 | 2023 | Jardiance |
| Teleflex LLC | $14.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kirk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.